Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness
Abstract
Use of a bisphosphonic acid derivative of formula: wherein R1 represents a hydrogen atom, a halogen atom, a hydroxyl, an amino, a mono (C1-C4) alkylamino, di (C1-C4) amino; R2 represents a halogen atom, a linear alkyl comprising from 1 to 5 carbon atoms unsubstituted or substituted by a group selected from a chlorine atom, a hydroxyl, amino, monoalkyl (C1-C4) alkylamino, di (C1-C4) amino; a cycloalkyl (C3-C7) amino, or R2 represents a phenoxy, a phenyl, a thiol, a phenylthio a chlorophenylthio, a pyridyl, one pyridylmethyl a 1-pyridyl 1-hydroxymethyl, one imidazolylmethyl a thiomorpholin-4-yl . of a pharmaceutically acceptable salt thereof or a hydrate thereof in the preparation of a medicament for the treatment of lameness displayed with osteoarthritis, the osteocondriosis or enthesopathies of bone insertions of tendons, ligaments or the aponeurosis of the animal does not suffer or arthritis or fractures or exostosis.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
28 members in 16 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 9812388 | France | A | |
| 9902349 | France | W |
Members28
| Document | Office | Kind | |
|---|---|---|---|
| FR2784031A1 | France | A1 | |
| CA2345364A1 | Canada | A1 | |
| WO0020008A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5870399A | Australia | A | |
| BR9914257A | Brazil | A | |
| US2001006960A1 | United States of America | A1 | |
| EP1117410A1 | European Patent Office (EPO) | A1 | |
| ZA200102510B | South Africa | B | |
| FR2784031B1 | France | B1 | |
| JP2002526412A | Japan | A | |
| US6455514B2 | United States of America | B2 | |
| US2003032627A1 | United States of America | A1 | |
| AU765284B2 | Australia | B2 | |
| NZ510804A | New Zealand | A | |
| US6696429B2 | United States of America | B2 | |
| US2004110726A1 | United States of America | A1 | |
| EP1117410B1 | European Patent Office (EPO) | B1 | |
| AT314074TThis record | Austria | T | |
| ATE314074T1 | Austria | T1 | |
| DE69929218D1 | Germany | D1 | |
| DK1117410T3 | Denmark | T3 | |
| ES2251226T3 | Spain | T3 | |
| PT1117410E | Portugal | E | |
| DE69929218T2 | Germany | T2 | |
| US2006183717A1 | United States of America | A1 | |
| CA2345364C | Canada | C | |
| CY1104974T1 | Cyprus | T1 | |
| US7915239B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99946282
Titles2
- German
- VERWENDUNG VON BISPHOSPHONSAÜRE DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON LAHMEN
- English
- USE OF BISPHOSPHONATE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF LAME
Classification
- CPC, 6
- A61K31/663
- A61K31/675
- A61P19/00
- A61P19/02
- A61P19/08
- A61P43/00
- IPC, 4
- A61K31 375
- A61K31 663
- A61K31 675
- A61P19 02